WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2006

Apr 7, 2006

SEC Form 4/A — Form 4/A

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2006-02-24

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2006-02-24	Common Stock	A	9000	—	Acquired	210839.1178	Direct
2006-02-24	Common Stock	A	4698.4932	$32.5850	Acquired	14411.5414	Indirect
2006-02-24	Common Stock	A	22	$32.7800	Acquired	14433.5414	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2006-02-24	Stock Option (Right to Buy)	$32.5850	A	74257	Acquired	2016-02-24	Common Stock (74257.00)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	771.1149	Indirect

Footnotes

F1: Additional amount of shares due to achieving above targeted amount for first performance period of 3/7/05 Performance Vested Restricted Share grant.

F2: The reporting person mistakenly filed a Form 4 reporting an acquisition of 25,381 shares of common stock on 2/24/2006 that did not in fact occur. [On that date the Reporting Person was granted performance [shares/units] which are not reportable unless and until certain performance vesting requirements (not tied to stock price) are met.] As of 2/24/2006, the Reporting Person owned only 210,839.1178 shares of common stock.

F3: Bonus and incentive shares granted on 2/24/06.

F4: The original acquisition of bonus and incentive shares on 2/24/05 was reported as all Direct ownership. This amount should have been reported as Indirector ownership under Non-Qualified Deferred Compensation.

F5: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.

F6: Amount in error as the incorrect price was used to calculate the number of shares.